RNA-binding protein FUS

RNA-binding protein FUS (Fused in Sarcoma), also known as translocated in liposarcoma (TLS), is a protein that, in humans, is encoded by the FUS gene. FUS is a member of the FET family of RNA-binding proteins, which also includes EWSR1 and TAF15. These proteins are involved in various aspects of RNA metabolism, including RNA splicing, RNA transport, and RNA transcription. Mutations in the FUS gene have been implicated in several diseases, most notably amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), making it a significant focus of medical research.

Function

FUS plays a critical role in the maintenance of genomic integrity. It is involved in the repair of DNA damage, regulation of gene expression, and the processing of pre-mRNA. FUS recognizes and binds to RNA via its RNA recognition motifs (RRMs) and facilitates the export of mRNA from the nucleus to the cytoplasm. Additionally, FUS participates in the response to cellular stress and has been shown to relocate from the nucleus to the cytoplasm under stress conditions.

Pathology

Mutations in the FUS gene are associated with several neurodegenerative diseases. In ALS, these mutations lead to the mislocalization and aggregation of FUS protein in the cytoplasm of neurons, contributing to neuronal death. Similarly, in FTLD, FUS mutations result in the formation of pathological inclusions in the brain. The exact mechanisms by which FUS mutations cause these diseases are not fully understood, but they are believed to involve disruptions in normal RNA processing and transport, leading to neuronal dysfunction and death.

Clinical Significance

The discovery of FUS mutations in ALS and FTLD has provided new insights into the pathogenesis of these conditions and has opened up potential avenues for therapeutic intervention. Targeting the pathways affected by FUS dysfunction, such as RNA metabolism and cellular stress responses, may offer new strategies for treating these devastating diseases.

Research Directions

Current research on FUS is focused on understanding the precise molecular mechanisms by which FUS mutations lead to disease, identifying potential biomarkers for early diagnosis, and developing targeted therapies. Studies using model organisms, such as mice and zebrafish, are crucial for elucidating the role of FUS in normal physiology and disease.